mAbLAB - Innovative technology for online process control

Reference number 2017-00195
Coordinator CAPSENZE BIOSYSTEMS AB
Funding from Vinnova SEK 300 000
Project duration March 2017 - February 2018
Status Completed
Venture Innovative Startups
Call Innovativa startups fas 1 Våren 2017

Purpose and goal

CapSenze flow-based technology platform mAbLAB is the core of this VINNOVA-driven project and has its foundation for more than fifteen years of research and development. CapSenze´s work on instrument development is largely based on this research conducted at the Division of Biotechnology at Lund University.

Expected results and effects

CapSenze has developed an analytical flow-injection method with a range of innovative hardware solutions as well as a smart and user-friendly software. These components together form a technology platform that is very suitable for performing accurate online measurements of a bioprocess. With this newly developed Swedish analysis technology, our ambition in this project is to take a final step toward the commercialization of the mAbLAB method for online-based quality control of mAb production focusing on the global pharmaceutical industry.

Planned approach and implementation

CapSenze Technology Platform mAbLAB has been found to be in the category of self-certification in the following EU directives: Low Voltage (LVD), Machine, Electromagnetic Compatibility (EMC) and Electronics Waste. Following a procurement process, this resulted in a work that included a number of occasions where LVD and EMC validation were carried out in a custom laboratory at the company Jan Linders AB in Gothenburg.

The project description has been provided by the project members themselves and the text has not been looked at by our editors.